(Q36735197)

16 August 2017

1 reference

title

Opioid conversions in acute care (English)

1 reference

16 August 2017

Asad E Patanwala

1

1 reference

16 August 2017

Jeremiah Duby

series ordinal

2

1 reference

16 August 2017

Dustin Waters

series ordinal

3

1 reference

16 August 2017

Brian L Erstad

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

13 February 2007

1 reference

Annals of Pharmacotherapy

16 August 2017

published in

1 reference

16 August 2017

volume

41

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

255-266

1 reference

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

16 August 2017

cites work

1 reference

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

21 January 2018

1 reference

Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain

21 January 2018

1 reference

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

21 January 2018

1 reference

Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study

21 January 2018

1 reference

Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation

21 January 2018

1 reference

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

21 January 2018

1 reference

Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA.

21 January 2018

1 reference

A randomized, double-blind study comparing morphine with fentanyl in prehospital analgesia

21 January 2018

1 reference

Controlled-release oxycodone and morphine in cancer related pain.

21 January 2018

1 reference

A comparison of subcutaneous morphine and fentanyl in hospice cancer patients.

21 January 2018

1 reference

Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients

21 January 2018

1 reference

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study

21 January 2018

1 reference

Rapid switching between transdermal fentanyl and methadone in cancer patients

21 January 2018

1 reference

Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

21 January 2018

1 reference

Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences

21 January 2018

1 reference

Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl

21 January 2018

1 reference

Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia

21 January 2018

1 reference

An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population

21 January 2018

1 reference

Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study.

21 January 2018

1 reference

Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain

21 January 2018

1 reference

A comparison of morphine, pethidine and fentanyl in the postsurgical patient-controlled analgesia environment.

21 January 2018

1 reference

Clinical application of opioid equianalgesic data

21 January 2018

1 reference

Opioid equianalgesic calculations

21 January 2018

1 reference

Accuracy in equianalgesic dosing. conversion dilemmas

21 January 2018

1 reference

Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing

21 January 2018

1 reference

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

21 January 2018

1 reference

Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain

21 January 2018

1 reference

Morphine: continuous intravenous infusion versus intramuscular injections for postoperative pain relief

21 January 2018

1 reference

Kinetics of intravenous and intramuscular morphine

21 January 2018

1 reference

Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients.

21 January 2018

1 reference

A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer

21 January 2018

1 reference

Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.

21 January 2018

1 reference

A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl

21 January 2018

1 reference

A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain

21 January 2018

1 reference

Transdermal fentanyl for pain control in patients with cancer

21 January 2018

1 reference

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients

21 January 2018

1 reference

The dilemma of conversion from systemic to epidural morphine: a proposed conversion tool for treatment of cancer pain.

21 January 2018

1 reference

Intrathecal infusional therapies for intractable pain: patient management guidelines

21 January 2018

1 reference

Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study

21 January 2018

1 reference

The conversion challenge: from intrathecal to oral morphine

21 January 2018

1 reference

Methadone use in cancer patients with pain: a review

21 January 2018

1 reference

Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H421

1 reference

release_llgtpefu4baohjkhbx756vv4ta

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/llgtpefu4baohjkhbx756vv4ta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference